DOCSLIB.ORG
Explore
Sign Up
Log In
Upload
Search
Home
» Tags
» Recombinant antibodies
Recombinant antibodies
Inhibitory Monoclonal Antibodies and Their Recombinant Derivatives Targeting Surface-Exposed Carbonic Anhydrase XII on Cancer Cells
Evaluation of Cellular Mechanisms Involved in Recombinant Antibody Expression in Transiently Transfected Chinese Hamster Ovary Cells
Recombinant Single-Chain Antibodies with Various Oligopeptide Tails for Targeted Gene Delivery
Design and Production of Bispecific Antibodies
Isolation of Specific Human Recombinant Antibodies Against Glycoprotein 41 of HIV
Development of Recombinant Antibodies for Diagnostic Applications by Protein Engineering
An Autoreactive Antibody from an SLE/HIV-1 Individual Broadly Neutralizes HIV-1
Directed Selection of Recombinant Human Monoclonal Antibodies to Herpessimplex Virus Glycoproteins from Phage Display Libraries
6 Steps to Optimize Your Recombinant Antibody Expression White Paper White Paper
Richard Broeker1, Monica Nguyen1, and Laura Doepker*2
Recombinant Antibodies for Academia: a Practical Approach
Bispecific Antibodies Targeting Tumor-Associated Antigens And
Novel Targeting Strategies Using Recombinant Antibodies for Early Diagnosis and Therapy of Ovarian Cancer
Bispecific Antibody Development Programs
Recombinant Antibodies and Vaccines for Viruses
Recombinant Antibodies K a Smith, P N Nelson, P Warren, S J Astley, P G Murray, J Greenman
Co-Evolution of a Broadly Neutralizing HIV-1 Antibody and Founder Virus
SARS-Cov-2 Neutralizing Human Recombinant Antibodies Selected from Pre-Pandemic Healthy Donors Binding at RBD-ACE2 Interface
Top View
Developing Recombinant Antibodies by Phage Display Against Infectious Diseases and Toxins for Diagnostics and Therapy
Transient Expression of Human Antibodies in Mammalian Cells
Current Advancements in Addressing Key Challenges of Therapeutic Antibody Design, Manufacture, and Formulation
Influence of Structural Variations on Biological Activity of Anti-PSMA Scfv and Immunotoxins Targeting Prostate Cancer
Recombinant Antibody Expression Overview 01 Introduction
High-Titer Expression of Recombinant Antibodies by Transiently Transfected HEK 293-6E Cell Cultures
Recombinant Antibody Expression and Purification
Generation of Monoclonal Antibody-Producing Mammalian Cell Lines
From Polyclonal Sera to Recombinant Antibodies: a Review of Immunological Detection of Gluten in Foodstuff
Directed Selection of Recombinant Human Monoclonal Antibodies To
Reafinity Recombinant Antibodies
High Level Transient Production of Recombinant Antibodies and Antibody Fusion Proteins in HEK293 Cells
Recombinant Anti-Virus Antibodies
Engineered Recombinant Single Chain Variable Fragment of Monoclonal Antibody Provides Protection to Chickens Infected with H9N2 Avian Influenza
Optimizing Signal Peptides for Expression of Recombinant Antibodies in HEK293 Cells
Drugs of the Future - Bispecific Antibodies an Investigation of Future Development Needs
Human Anti-CD30 Recombinant Antibodies by Guided Phage
Advancements in Mrna Encoded Antibodies for Passive Immunotherapy
SARS-Cov-2 Neutralizing Human Recombinant Antibodies Selected From
Generation and Application of Recombinant Antibody Fragments for Prostate Cancer Detection
Neutralizing Monoclonal Anti-SARS-Cov-2 Antibodies Isolated from Immunized Rabbits Define Novel Vulnerable Spike-Protein Epitope